{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:51:45Z","timestamp":1788951105952,"version":"build-2803163510"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,9]],"date-time":"2018-04-09T00:00:00Z","timestamp":1523232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,4,9]],"date-time":"2018-04-09T00:00:00Z","timestamp":1523232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Plac1 is an X-linked trophoblast gene expressed at high levels in the placenta, but not in adult somatic tissues other than the testis. Plac1 however is re-expressed in several solid tumors and in most human cancer cell lines. To explore the role of Plac1 in cancer progression, Plac1 was reduced by RNA interference in EO771 mammary carcinoma cells. EO771 \u201cknockdown\u201d (KD) resulted in 50% reduction in proliferation\n                    <jats:italic>in vitro<\/jats:italic>\n                    and impaired tumor growth in syngeneic mice; however, tumor growth in SCID mice was equivalent to tumor cells expressing a non-silencing control RNA, suggesting that Plac1 regulated adaptive immunity. Gene expression profiling of Plac1 KD cells indicated reduction in several inflammatory and immune factors, including Cxcl1, Ccl5, Ly6a\/Sca-1, Ly6c and Lif. Treatment of mice engrafted with wild-type EO771 cells with a Cxcr2 antagonist impaired tumor growth, reduced myeloid-derived suppressor cells and regulatory T cells, while increasing macrophages, dendritic cells, NK cells and the penetration of CD8+ T cells into the tumor bed. Cxcl1 KD phenocopied the effects of Plac1 KD on tumor growth, and overexpression of Cxcl1 partially rescued Plac1 KD cells. These results reveal that Plac1 modulates a tolerogenic tumor microenvironment in part by modulating the chemokine axis.\n                  <\/jats:p>","DOI":"10.1038\/s41598-018-24022-w","type":"journal-article","created":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T23:24:30Z","timestamp":1522797870000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Plac1 Is a Key Regulator of the Inflammatory Response and Immune Tolerance In Mammary Tumorigenesis"],"prefix":"10.1038","volume":"8","author":[{"given":"Hongyan","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxia","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alston","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nairuthya","family":"Vijayendra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkata","family":"Doodala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spencer","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis M.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert I.","family":"Glazer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,9]]},"reference":[{"key":"24022_CR1","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/pd.2506","volume":"30","author":"M Fant","year":"2011","unstructured":"Fant, M., Farina, A., Nagaraja, R. & Schlessinger, D. PLAC1 (Placenta-specific 1): a novel, X-linked gene with roles in reproductive and cancer biology. Prenat. Diagn. 30, 497\u2013502 (2011).","journal-title":"Prenat. Diagn."},{"key":"24022_CR2","first-page":"18","volume":"7","author":"WA Silva Jr","year":"2007","unstructured":"Silva, W. A. Jr et al. PLAC1, a trophoblast-specific cell surface protein, is expressed in a range of human tumors and elicits spontaneous antibody responses. Cancer immunity 7, 18 (2007).","journal-title":"Cancer immunity"},{"key":"24022_CR3","first-page":"19","volume":"7","author":"LJ Old","year":"2007","unstructured":"Old, L. J. Cancer is a somatic cell pregnancy. Cancer immunity 7, 19 (2007).","journal-title":"Cancer immunity"},{"key":"24022_CR4","doi-asserted-by":"publisher","first-page":"13493","DOI":"10.1073\/pnas.0906840106","volume":"106","author":"A Grigoriadis","year":"2009","unstructured":"Grigoriadis, A. et al. CT-X antigen expression in human breast cancer. Proc. Natl. Acad. Sci. USA 106, 13493\u201313498, https:\/\/doi.org\/10.1073\/pnas.0906840106 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"24022_CR5","doi-asserted-by":"publisher","first-page":"9528","DOI":"10.1158\/0008-5472.CAN-07-1350","volume":"67","author":"M Koslowski","year":"2007","unstructured":"Koslowski, M. et al. A placenta-specific gene ectopically activated in many human cancers is essentially involved in malignant cell processes. Cancer Res. 67, 9528\u20139534 (2007).","journal-title":"Cancer Res."},{"key":"24022_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-11-107","volume":"11","author":"X Wang","year":"2014","unstructured":"Wang, X., Baddoo, M. C. & Yin, Q. The placental specific gene, PLAC1, is induced by the Epstein-Barr virus and is expressed in human tumor cells. Virology journal 11, 107, https:\/\/doi.org\/10.1186\/1743-422X-11-107 (2014).","journal-title":"Virology journal"},{"key":"24022_CR7","doi-asserted-by":"publisher","first-page":"807849","DOI":"10.1155\/2013\/807849","volume":"2013","author":"EJ Devor","year":"2013","unstructured":"Devor, E. J. & Leslie, K. K. The oncoplacental gene placenta-specific protein 1 is highly expressed in endometrial tumors and cell lines. Obstetrics and gynecology international 2013, 807849, https:\/\/doi.org\/10.1155\/2013\/807849 (2013).","journal-title":"Obstetrics and gynecology international"},{"key":"24022_CR8","doi-asserted-by":"publisher","first-page":"12372","DOI":"10.1073\/pnas.1109363108","volume":"108","author":"HW Cheung","year":"2011","unstructured":"Cheung, H. W. et al. Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer. Proc. Natl. Acad. Sci. USA 108, 12372\u201312377, https:\/\/doi.org\/10.1073\/pnas.1109363108 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"24022_CR9","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1002\/ijc.23341","volume":"122","author":"XY Dong","year":"2008","unstructured":"Dong, X. Y. et al. Plac1 is a tumor-specific antigen capable of eliciting spontaneous antibody responses in human cancer patients. Int. J. Cancer 122, 2038\u20132043 (2008).","journal-title":"Int. J. Cancer"},{"key":"24022_CR10","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00535-013-0811-4","volume":"49","author":"F Liu","year":"2014","unstructured":"Liu, F. et al. Identification of two new HLA-A*0201-restricted cytotoxic T lymphocyte epitopes from colorectal carcinoma-associated antigen PLAC1\/CP1. J. Gastroenterol. 49, 419\u2013426, https:\/\/doi.org\/10.1007\/s00535-013-0811-4 (2014).","journal-title":"J. Gastroenterol."},{"key":"24022_CR11","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1053\/j.gastro.2008.01.029","volume":"134","author":"FF Liu","year":"2008","unstructured":"Liu, F. F. et al. The specific immune response to tumor antigen CP1 and its correlation with improved survival in colon cancer patients. Gastroenterology 134, 998\u20131006 (2008).","journal-title":"Gastroenterology"},{"key":"24022_CR12","doi-asserted-by":"publisher","first-page":"e16617","DOI":"10.1371\/journal.pone.0016617","volume":"6","author":"T Otsubo","year":"2011","unstructured":"Otsubo, T. et al. MicroRNA-126 Inhibits SOX2 Expression and Contributes to Gastric Carcinogenesis. PloS one 6, e16617 (2011).","journal-title":"PloS one"},{"key":"24022_CR13","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s00262-014-1594-z","volume":"63","author":"R Ghods","year":"2014","unstructured":"Ghods, R. et al. High placenta-specific 1\/low prostate-specific antigen expression pattern in high-grade prostate adenocarcinoma. Cancer Immunol. Immunother. 63, 1319\u20131327, https:\/\/doi.org\/10.1007\/s00262-014-1594-z (2014).","journal-title":"Cancer Immunol. Immunother."},{"key":"24022_CR14","doi-asserted-by":"publisher","first-page":"4349","DOI":"10.1158\/0008-5472.CAN-13-0322","volume":"73","author":"H Yuan","year":"2013","unstructured":"Yuan, H. et al. PPARdelta induces estrogen receptor-positive mammary neoplasia through an inflammatory and metabolic phenotype linked to mTOR activation. Cancer Res. 73, 4349\u20134361, https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-0322 (2013).","journal-title":"Cancer Res."},{"key":"24022_CR15","doi-asserted-by":"publisher","first-page":"e16344","DOI":"10.1371\/journal.pone.0016344","volume":"6","author":"T Adhikary","year":"2011","unstructured":"Adhikary, T. et al. Genomewide analyses define different modes of transcriptional regulation by peroxisome proliferator-activated receptor-beta\/delta (PPARbeta\/delta). PloS one 6, e16344, https:\/\/doi.org\/10.1371\/journal.pone.0016344 (2011).","journal-title":"PloS one"},{"key":"24022_CR16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ccr.2004.06.027","volume":"6","author":"MI Torres-Arzayus","year":"2004","unstructured":"Torres-Arzayus, M. I. et al. High tumor incidence and activation of the PI3K\/AKT pathway in transgenic mice define AIB1 as an oncogene. Cancer cell 6, 263\u2013274 (2004).","journal-title":"Cancer cell"},{"key":"24022_CR17","doi-asserted-by":"publisher","first-page":"4102","DOI":"10.1158\/0008-5472.CAN-09-4080","volume":"70","author":"MI Torres-Arzayus","year":"2010","unstructured":"Torres-Arzayus, M. I., Zhao, J., Bronson, R. & Brown, M. Estrogen-dependent and estrogen-independent mechanisms contribute to AIB1-mediated tumor formation. Cancer Res. 70, 4102\u20134111, https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-4080 (2010).","journal-title":"Cancer Res."},{"key":"24022_CR18","doi-asserted-by":"publisher","first-page":"28607","DOI":"10.1074\/jbc.M109.031120","volume":"284","author":"M Koslowski","year":"2009","unstructured":"Koslowski, M. et al. Selective activation of trophoblast-specific PLAC1 in breast cancer by CCAAT\/enhancer-binding protein beta (C\/EBPbeta) isoform 2. J. Biol. Chem. 284, 28607\u201328615 (2009).","journal-title":"J. Biol. Chem."},{"key":"24022_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-570","volume":"13","author":"M Wagner","year":"2013","unstructured":"Wagner, M. et al. NCOA3 is a selective co-activator of estrogen receptor alpha-mediated transactivation of PLAC1 in MCF-7 breast cancer cells. BMC cancer 13, 570, https:\/\/doi.org\/10.1186\/1471-2407-13-570 (2013).","journal-title":"BMC cancer"},{"key":"24022_CR20","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1126\/science.277.5328.965","volume":"277","author":"SL Anzick","year":"1997","unstructured":"Anzick, S. L. et al. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277, 965\u2013968 (1997).","journal-title":"Science"},{"key":"24022_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0960-0760(02)00254-6","volume":"83","author":"L Liao","year":"2002","unstructured":"Liao, L. et al. Molecular structure and biological function of the cancer-amplified nuclear receptor coactivator SRC-3\/AIB1. J. Steroid Biochem. Mol. Biol. 83, 3\u201314 (2002).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"24022_CR22","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1023\/A:1025900908026","volume":"8","author":"SL Grimm","year":"2003","unstructured":"Grimm, S. L. & Rosen, J. M. The role of C\/EBPbeta in mammary gland development and breast cancer. J. Mammary Gland Biol. Neoplasia 8, 191\u2013204 (2003).","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"24022_CR23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1477-7827-5-6","volume":"5","author":"L Lunghi","year":"2007","unstructured":"Lunghi, L., Ferretti, M. E., Medici, S., Biondi, C. & Vesce, F. Control of human trophoblast function. Reproductive biology and endocrinology: RB&E 5, 6, https:\/\/doi.org\/10.1186\/1477-7827-5-6 (2007).","journal-title":"Reproductive biology and endocrinology: RB&E"},{"key":"24022_CR24","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.4049\/jimmunol.136.5.1668","volume":"136","author":"DA Clark","year":"1986","unstructured":"Clark, D. A., Chaput, A. & Tutton, D. Active suppression of host-vs-graft reaction in pregnant mice. VII. Spontaneous abortion of allogeneic CBA\/J \u00d7 DBA\/2 fetuses in the uterus of CBA\/J mice correlates with deficient non-T suppressor cell activity. J. Immunol. 136, 1668\u20131675 (1986).","journal-title":"J. Immunol."},{"key":"24022_CR25","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","volume":"27","author":"SL Topalian","year":"2015","unstructured":"Topalian, S. L., Drake, C. G. & Pardoll, D. M. Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer cell 27, 450\u2013461, https:\/\/doi.org\/10.1016\/j.ccell.2015.03.001 (2015).","journal-title":"Cancer cell"},{"key":"24022_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1028-7","volume":"17","author":"B Li","year":"2016","unstructured":"Li, B. et al. Comprehensive analyses of tumor immunity: implications for cancer immunotherapy. Genome biology 17, 174, https:\/\/doi.org\/10.1186\/s13059-016-1028-7 (2016).","journal-title":"Genome biology"},{"key":"24022_CR27","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.placenta.2011.08.011","volume":"32","author":"Y Chen","year":"2011","unstructured":"Chen, Y., Moradin, A., Schlessinger, D. & Nagaraja, R. RXRalpha and LXR activate two promoters in placenta- and tumor-specific expression of PLAC1. Placenta 32, 877\u2013884, https:\/\/doi.org\/10.1016\/j.placenta.2011.08.011 (2011).","journal-title":"Placenta"},{"key":"24022_CR28","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1006\/geno.2000.6302","volume":"68","author":"M Cocchia","year":"2000","unstructured":"Cocchia, M. et al. PLAC1, an Xq26 gene with placenta-specific expression. Genomics 68, 305\u2013312 (2000).","journal-title":"Genomics"},{"key":"24022_CR29","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/ni.1713","volume":"10","author":"JS Bezbradica","year":"2009","unstructured":"Bezbradica, J. S. & Medzhitov, R. Integration of cytokine and heterologous receptor signaling pathways. Nature immunology 10, 333\u2013339, https:\/\/doi.org\/10.1038\/ni.1713 (2009).","journal-title":"Nature immunology"},{"key":"24022_CR30","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.cell.2012.04.042","volume":"150","author":"S Acharyya","year":"2012","unstructured":"Acharyya, S. et al. A CXCL1 paracrine network links cancer chemoresistance and metastasis. Cell 150, 165\u2013178, https:\/\/doi.org\/10.1016\/j.cell.2012.04.042 (2012).","journal-title":"Cell"},{"key":"24022_CR31","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/nature13638","volume":"515","author":"D Di Mitri","year":"2014","unstructured":"Di Mitri, D. et al. Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer. Nature 515, 134\u2013137, https:\/\/doi.org\/10.1038\/nature13638 (2014).","journal-title":"Nature"},{"key":"24022_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-781","volume":"14","author":"A Zou","year":"2014","unstructured":"Zou, A. et al. Elevated CXCL1 expression in breast cancer stroma predicts poor prognosis and is inversely associated with expression of TGF-beta signaling proteins. BMC cancer 14, 781, https:\/\/doi.org\/10.1186\/1471-2407-14-781 (2014).","journal-title":"BMC cancer"},{"key":"24022_CR33","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nm1764","volume":"14","author":"G Finak","year":"2008","unstructured":"Finak, G. et al. Stromal gene expression predicts clinical outcome in breast cancer. Nat. Med. 14, 518\u2013527, https:\/\/doi.org\/10.1038\/nm1764 (2008).","journal-title":"Nat. Med."},{"key":"24022_CR34","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1677\/erc.1.01301","volume":"14","author":"I Bieche","year":"2007","unstructured":"Bieche, I. et al. CXC chemokines located in the 4q21 region are up-regulated in breast cancer. Endocrine-related cancer 14, 1039\u20131052, https:\/\/doi.org\/10.1677\/erc.1.01301 (2007).","journal-title":"Endocrine-related cancer"},{"key":"24022_CR35","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/10408360601040970","volume":"44","author":"N Harbeck","year":"2007","unstructured":"Harbeck, N., Schmitt, M., Paepke, S., Allgayer, H. & Kates, R. E. Tumor-associated proteolytic factors uPA and PAI-1: critical appraisal of their clinical relevance in breast cancer and their integration into decision-support algorithms. Crit. Rev. Clin. Lab. Sci. 44, 179\u2013201, https:\/\/doi.org\/10.1080\/10408360601040970 (2007).","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"24022_CR36","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S0143-4004(03)00063-8","volume":"24","author":"PK Lala","year":"2003","unstructured":"Lala, P. K. & Chakraborty, C. Factors regulating trophoblast migration and invasiveness: possible derangements contributing to pre-eclampsia and fetal injury. Placenta 24, 575\u2013587 (2003).","journal-title":"Placenta"},{"key":"24022_CR37","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1593\/neo.08902","volume":"10","author":"C Grange","year":"2008","unstructured":"Grange, C., Lanzardo, S., Cavallo, F., Camussi, G. & Bussolati, B. Sca-1 identifies the tumor-initiating cells in mammary tumors of BALB-neuT transgenic mice. Neoplasia 10, 1433\u20131443 (2008).","journal-title":"Neoplasia"},{"key":"24022_CR38","doi-asserted-by":"publisher","first-page":"8671","DOI":"10.1158\/0008-5472.CAN-07-1486","volume":"67","author":"JC Liu","year":"2007","unstructured":"Liu, J. C., Deng, T., Lehal, R. S., Kim, J. & Zacksenhaus, E. Identification of tumorsphere- and tumor-initiating cells in HER2\/Neu-induced mammary tumors. Cancer Res. 67, 8671\u20138681 (2007).","journal-title":"Cancer Res."},{"key":"24022_CR39","doi-asserted-by":"publisher","first-page":"7820","DOI":"10.1073\/pnas.1103441108","volume":"108","author":"G Upadhyay","year":"2011","unstructured":"Upadhyay, G. et al. Stem cell antigen-1 enhances tumorigenicity by disruption of growth differentiation factor-10 (GDF10)-dependent TGF-beta signaling. Proc. Natl. Acad. Sci. USA 108, 7820\u20137825, https:\/\/doi.org\/10.1073\/pnas.1103441108 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"24022_CR40","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1158\/1940-6207.CAPR-11-0256","volume":"5","author":"H Yuan","year":"2012","unstructured":"Yuan, H., Upadhyay, G., Yin, Y., Kopelovich, L. & Glazer, R. I. Stem cell antigen-1 deficiency enhances the chemopreventive effect of peroxisome proliferator-activated receptor{gamma} activation. Cancer prevention research 5, 51\u201360 (2012).","journal-title":"Cancer prevention research"},{"key":"24022_CR41","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/ni.1937","volume":"11","author":"SK Biswas","year":"2010","unstructured":"Biswas, S. K. & Mantovani, A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nature immunology 11, 889\u2013896, https:\/\/doi.org\/10.1038\/ni.1937 (2010).","journal-title":"Nature immunology"},{"key":"24022_CR42","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1158\/2159-8274.CD-10-0028","volume":"1","author":"DG DeNardo","year":"2011","unstructured":"DeNardo, D. G. et al. Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. Cancer discovery 1, 54\u201367, https:\/\/doi.org\/10.1158\/2159-8274.CD-10-0028 (2011).","journal-title":"Cancer discovery"},{"key":"24022_CR43","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ejphar.2009.01.018","volume":"606","author":"MC Hendriks-Balk","year":"2009","unstructured":"Hendriks-Balk, M. C. et al. Sphingosine-1-phosphate regulates RGS2 and RGS16 mRNA expression in vascular smooth muscle cells. Eur. J. Pharmacol. 606, 25\u201331, https:\/\/doi.org\/10.1016\/j.ejphar.2009.01.018 (2009).","journal-title":"Eur. J. Pharmacol."},{"key":"24022_CR44","doi-asserted-by":"crossref","unstructured":"Jackman S. K. X. & Fant M. Plac1 (Placenta-specific 1) Is Essential for Normal Placental and EmbryonicDevelopment. Mol. Reprod. Dev. in press (2012).","DOI":"10.1002\/mrd.22062"},{"key":"24022_CR45","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3389\/fimmu.2012.00263","volume":"3","author":"A Stadtmann","year":"2012","unstructured":"Stadtmann, A. & Zarbock, A. CXCR2: From Bench to Bedside. Frontiers in immunology 3, 263, https:\/\/doi.org\/10.3389\/fimmu.2012.00263 (2012).","journal-title":"Frontiers in immunology"},{"key":"24022_CR46","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nrd2734","volume":"8","author":"R Horuk","year":"2009","unstructured":"Horuk, R. Chemokine receptor antagonists: overcoming developmental hurdles. Nature reviews. Drug discovery 8, 23\u201333, https:\/\/doi.org\/10.1038\/nrd2734 (2009).","journal-title":"Nature reviews. Drug discovery"},{"key":"24022_CR47","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1172\/JCI61067","volume":"122","author":"T Jamieson","year":"2012","unstructured":"Jamieson, T. et al. Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis. J. Clin. Invest. 122, 3127\u20133144, https:\/\/doi.org\/10.1172\/JCI61067 (2012).","journal-title":"J. Clin. Invest."},{"key":"24022_CR48","doi-asserted-by":"publisher","first-page":"237ra267","DOI":"10.1126\/scitranslmed.3007974","volume":"6","author":"SL Highfill","year":"2014","unstructured":"Highfill, S. L. et al. Disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacy. Science translational medicine 6, 237ra267, https:\/\/doi.org\/10.1126\/scitranslmed.3007974 (2014).","journal-title":"Science translational medicine"},{"key":"24022_CR49","first-page":"1299","volume":"13","author":"LJ Dunham","year":"1953","unstructured":"Dunham, L. J. & Stewart, H. L. A survey of transplantable and transmissible animal tumors. J. Natl. Cancer Inst. 13, 1299\u20131377 (1953).","journal-title":"J. Natl. Cancer Inst."},{"key":"24022_CR50","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1752-8062.2008.00041.x","volume":"1","author":"J Lindsay","year":"2008","unstructured":"Lindsay, J. et al. ErbB2 induces Notch1 activity and function in breast cancer cells. Clinical and translational science 1, 107\u2013115, https:\/\/doi.org\/10.1111\/j.1752-8062.2008.00041.x (2008).","journal-title":"Clinical and translational science"},{"key":"24022_CR51","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1158\/0008-5472.CAN-08-2446","volume":"69","author":"Y Yin","year":"2009","unstructured":"Yin, Y., Yuan, H., Zeng, X., Kopelovich, L. & Glazer, R. I. Inhibition of peroxisome proliferator-activated receptor gamma increases estrogen receptor-dependent tumor specification. Cancer Res. 69, 687\u2013694, https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-2446 (2009).","journal-title":"Cancer Res."},{"key":"24022_CR52","doi-asserted-by":"publisher","first-page":"e0134783","DOI":"10.1371\/journal.pone.0134783","volume":"10","author":"JF de Vasconcellos","year":"2015","unstructured":"de Vasconcellos, J. F. et al. SB225002 Induces Cell Death and Cell Cycle Arrest in Acute Lymphoblastic Leukemia Cells through the Activation of GLIPR1. PloS one 10, e0134783, https:\/\/doi.org\/10.1371\/journal.pone.0134783 (2015).","journal-title":"PloS one"},{"key":"24022_CR53","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.1172\/JCI42754","volume":"121","author":"H Ijichi","year":"2011","unstructured":"Ijichi, H. et al. Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma. J. Clin. Invest. 121, 4106\u20134117, https:\/\/doi.org\/10.1172\/JCI42754 (2011).","journal-title":"J. Clin. Invest."},{"key":"24022_CR54","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1093\/jnci\/82.13.1107","volume":"82","author":"P Skehan","year":"1990","unstructured":"Skehan, P. et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 82, 1107\u20131112 (1990).","journal-title":"J. Natl. Cancer Inst."},{"key":"24022_CR55","doi-asserted-by":"publisher","first-page":"3950","DOI":"10.1158\/0008-5472.CAN-04-3990","volume":"65","author":"Y Yin","year":"2005","unstructured":"Yin, Y. et al. Peroxisome proliferator-activated receptor delta and gamma agonists differentially alter tumor differentiation and progression during mammary carcinogenesis. Cancer Res. 65, 3950\u20133957 (2005).","journal-title":"Cancer Res."},{"key":"24022_CR56","doi-asserted-by":"publisher","first-page":"e16215","DOI":"10.1371\/journal.pone.0016215","volume":"6","author":"CB Pollock","year":"2011","unstructured":"Pollock, C. B. et al. PPARdelta activation acts cooperatively with 3-phosphoinositide-dependent protein kinase-1 to enhance mammary tumorigenesis. PloS one 6, e16215, https:\/\/doi.org\/10.1371\/journal.pone.0016215 (2011).","journal-title":"PloS one"},{"key":"24022_CR57","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/mc.20119","volume":"44","author":"Y Yin","year":"2005","unstructured":"Yin, Y. et al. Characterization of medroxyprogesterone and DMBA-induced multilineage mammary tumors by gene expression profiling. Mol. Carcinog. 44, 42\u201350, https:\/\/doi.org\/10.1002\/mc.20119 (2005).","journal-title":"Mol. Carcinog."},{"key":"24022_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2007-8-5-r76","volume":"8","author":"JI Herschkowitz","year":"2007","unstructured":"Herschkowitz, J. I. et al. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome biology 8, R76, https:\/\/doi.org\/10.1186\/gb-2007-8-5-r76 (2007).","journal-title":"Genome biology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24022-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24022-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24022-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T18:35:27Z","timestamp":1693593327000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24022-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,9]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["24022"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-24022-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,9]]},"assertion":[{"value":"22 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"5717"}}